GlaxoSmithKline receives antitrust penalty: the agreement to delay the entry of generic drugs is illegal
With the coming Oil & Gas Asia Exhibition in Pakistan, ECHEMI rolls out a new bulk purchasing activity for its new and old customers. This activity will be valid before March 16 when the exhibition come to the end. The more you buy, the more money you will save.
How to join this bulk purchasing?
You can enjoy the most favorable prices via three steps:
First, you should come to the home page of ECHEMI, then you can see the the following page:
Second, input your demand and submit the inquiry.
Third, ECHEMI will give you a reply within 1 working day after receiving your inquiry.
Opportunity knocks but once! Come on, seize this opportunity right now!
2026-10-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
AiolosBio: The Middleman with an Eye for Opportunity in the Pharmaceutical Industry?
-
Breakthrough Collaboration: Johnson Pharmaceuticals and GSK Join Forces to Advance ADC Therapy HS-20093
-
GlaxoSmithKline Acquires Exclusive Licensing Rights for Johnson Pharmaceuticals' Promising ADC Drug HS-20089: A Potential Breakthrough Therapy for Gynecologic Cancers
-
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demand for Vaccines
-
3 billion, nearly 10 years, why GlaxoSmithKline again?
-
A large number of pharmaceutical companies are in trouble
-
GlaxoSmithKline HPV Vaccine Two-dose Schedule Approved in China
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
European EMA Removes About 100 Generic Drugs Involving Johnson & Johnson, Sandoz, Teva, etc.
-
Alipay, Baidu, and iFlytek Win Big—As the Government Spends $1.1 Billion on AI Healthcare, Is This a Lifeline or a Feeding Frenzy for Tech Giants?
Recommend Reading
-
$530 Million Lawsuit Unheard, $76 Million Counterclaim Filed: Is Qicai Chemical’s ‘Reputation Defense’ a Desperate Last Stand or a Calculated PR Gambit?
-
EFSA Evaluates Extended Use of Pasteurised Akkermansia muciniphila as a Novel Food
-
Brazil Confirms 32 Methanol Poisoning Cases Linked to Contaminated Alcoholic Beverages
-
India Accuses Balaji Amines of Manufacturing Pharma-Grade Propylene Glycol Without Drug Manufacturing Licence
-
EU Officially Approves Rapeseed Oil as a Low-Risk Active Substance Until 2040
-
Bottom-fishing and restocking boost ABS to a rapid rise in mid-January
-
Weak demand leads to consolidation in China's anhydrous hydrogen fluoride market
-
Maintenance Plan Increased; PP Prices Stabilize by End of December
-
Microcrystalline Cellulose: Applications in Pharmaceuticals
-
Mid-January Acetic Acid Market Trends Show a Strong Uptrend
- Hot Searches
- kerosene prices near me today
- denatured alcohol supplier
- jim tessa medication
- what's the price of kerosene
- retatrutide 20mg where to buy
- cetilistat buy
- sulfate manganese
- wholesale herbicide
- polypropylene price per ton in nigeria 2026
- where to buy anhydrous ammonia
- benzoic acid sds
- areprazole

